Next Generation Sequencing (NGS) Sample Preparation Market Report 2025

This next generation sequencing (NGS) sample preparation market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The next generation sequencing (NGS) sample preparation market size has grown rapidly in recent years. It will grow from $3.13 billion in 2024 to $3.6 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to increasing demand for high-throughput sequencing, reduction in sequencing costs, rise in genomic research, growing incidence of genetic disorders, and technological innovations in sample preparation.

The next generation sequencing (NGS) sample preparation market size is expected to see rapid growth in the next few years. It will grow to $6.2 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing adoption of NGS in diagnostics, expanding research in precision medicine, growing demand for nucleic acid sequencing, enhanced reimbursement for NGS-based tests, and ongoing innovations in NGS technologies. Major trends in the forecast period include integration of AI, advanced data analysis tools, advancements in reagent technology, non-invasive prenatal testing (NIPT), and integration of automation in sample preparation processes.

The rising incidence of infectious diseases is expected to drive the growth of the next-generation sequencing (NGS) sample preparation market in the coming years. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites, which can spread from person to person, either directly or indirectly. Factors such as increased global travel, urbanization, climate change, antimicrobial resistance, and the emergence of new pathogens contribute to the growing occurrence of these diseases. Next-generation sequencing sample preparation plays a vital role in addressing infectious diseases by enabling the rapid and accurate identification of pathogens, helping to monitor outbreaks, track transmission, and inform treatment strategies. For example, in September 2023, GOV.UK reported that tuberculosis (TB) cases in England increased by 7% in the first half of 2023 compared to the same period in 2022, with notifications rising from 2,251 to 2,408. Consequently, the growing incidence of infectious diseases will fuel the expansion of the next-generation sequencing (NGS) sample preparation market.

Leading companies in the next-generation sequencing (NGS) sample preparation market are focusing on automation, such as digital microfluidics platforms, to improve efficiency, reduce manual errors, and streamline sample processing for more precise and timely genomic analysis. Digital microfluidics platforms use electrical fields to manipulate small fluid volumes on a microchip, enabling automated and accurate sample handling for applications such as NGS sample preparation. For instance, in September 2023, INTEGRA Biosciences, a Switzerland-based provider of liquid handling and media preparation solutions, launched the MIRO CANVAS, a compact digital microfluidics platform designed for fully automated NGS sample preparation. This innovative system improves accuracy and efficiency by automating workflows, reducing hands-on time to just 15 minutes per run, and enabling immediate processing of clinical samples. The MIRO CANVAS aims to streamline NGS workflows and support advanced genomics research by preserving DNA integrity and minimizing reagent use.

In January 2023, QIAGEN NV, a biotechnology firm based in the Netherlands, acquired Verogen for $150 million. This acquisition is intended to strengthen QIAGEN's capabilities in forensic and genetic testing, broadening its product portfolio and market presence in the life sciences sector. Verogen, a forensic genomics company located in the United States, specializes in next-generation sequencing solutions tailored for forensic applications.

Major companies operating in the next generation sequencing (NGS) sample preparation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company (BD), Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Novogene Co. Ltd., Tecan Group Ltd, BGI Genomics Co. Ltd., Medgenome Inc., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., Oxford Nanopore Technologies Limited, New England Biolabs Inc., Pacific Biosciences of California Inc., Zymo Research Corporation, Psomagen Inc., Swift Biosciences Inc.

North America was the largest region in the next generation sequencing (NGS) sample preparation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in the next generation sequencing (NGS) sample preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next generation sequencing (NGS) sample preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Next-generation sequencing (NGS) sample preparation refers to the process of preparing DNA or RNA samples for sequencing using NGS technologies. This process involves several steps, including extraction, quantification, library preparation, and enrichment, to ensure that the samples are suitable for high-throughput sequencing and precise genomic analysis.

The key products and services in NGS sample preparation include workstations or instruments, reagents and consumables, and services. Workstations or instruments are specialized tools designed to automate and streamline the various stages of NGS sample preparation and sequencing, playing a crucial role in delivering efficient and accurate sequencing outcomes. The workflow includes steps such as library preparation, target enrichment, sample extraction or isolation, fragmentation, sample quantification, library quantification, quality control (QC), and pooling. Technologies used in this process include nanopore sequencing, sequencing by synthesis (SBS), single-molecule real-time (SMRT) sequencing, and ion semiconductor sequencing. Applications span across diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture and animal research, and more, with end users ranging from academic institutes and research centers to hospitals, clinics, pharmaceutical and biotech companies, and other sectors.

The next generation sequencing (NGS) sample preparation market research report is one of a series of new reports that provides next generation sequencing (NGS) sample preparation market statistics, including next generation sequencing (NGS) sample preparation industry global market size, regional shares, competitors with an next generation sequencing (NGS) sample preparation market share, detailed next generation sequencing (NGS) sample preparation market segments, market trends and opportunities, and any further data you may need to thrive in the next generation sequencing (NGS) sample preparation industry. This next generation sequencing (NGS) sample preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next generation sequencing (NGS) sample preparation market consists of revenues earned by entities by providing services such as library construction services, PCR amplification services, validation services, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation sequencing (NGS) sample preparation market also includes sales of preparation kits, sample tracking software, automation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.